Chen Y, Guan W, Wang M, Lin X
Int J Neuropsychopharmacol. 2024; 27(2).
PMID: 38365306
PMC: 10888523.
DOI: 10.1093/ijnp/pyae010.
He L, Fu Y, Tian Y, Wang X, Zhou X, Ding R
Molecules. 2023; 28(22).
PMID: 38005316
PMC: 10673223.
DOI: 10.3390/molecules28227594.
Asensi-Canto A, Rodriguez-Braun E, Beltran-Videla A, Hurtado A, Conesa-Zamora P
Front Oncol. 2023; 13:1238464.
PMID: 37841433
PMC: 10570506.
DOI: 10.3389/fonc.2023.1238464.
Younes S, Mourad N, Salla M, Rahal M, Hammoudi Halat D
Membranes (Basel). 2023; 13(4).
PMID: 37103862
PMC: 10144598.
DOI: 10.3390/membranes13040434.
Montiel-Davalos A, Ayala Y, Hernandez G
Front Cell Dev Biol. 2023; 11:1086964.
PMID: 36994107
PMC: 10042294.
DOI: 10.3389/fcell.2023.1086964.
Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases.
Racz B, Spengler G
Antibiotics (Basel). 2023; 12(1).
PMID: 36671340
PMC: 9855052.
DOI: 10.3390/antibiotics12010137.
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment.
Asensi-Canto A, Lopez-Abellan M, Castillo-Guardiola V, Hurtado A, Martinez-Penella M, Luengo-Gil G
Cancers (Basel). 2022; 14(13).
PMID: 35805019
PMC: 9265090.
DOI: 10.3390/cancers14133248.
Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells by Inhibiting Autophagy.
Chen Z, Zhu G, Sheng C, Lei J, Song S, Zhu J
Comput Intell Neurosci. 2022; 2022:5266770.
PMID: 35800695
PMC: 9256375.
DOI: 10.1155/2022/5266770.
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.
Rabin E, Kim M, Mozny A, Cardoza K, Bell A, Zhai L
Brain Behav Immun Health. 2022; 21:100449.
PMID: 35368609
PMC: 8968450.
DOI: 10.1016/j.bbih.2022.100449.
Deficient Autophagy in Microglia Aggravates Repeated Social Defeat Stress-Induced Social Avoidance.
Sakai M, Yu Z, Hirayama R, Nakasato M, Kikuchi Y, Ono C
Neural Plast. 2022; 2022:7503553.
PMID: 35222638
PMC: 8866015.
DOI: 10.1155/2022/7503553.
Repurposing autophagy regulators in brain tumors.
Petrosyan E, Fares J, Cordero A, Rashidi A, Arrieta V, Kanojia D
Int J Cancer. 2022; 151(2):167-180.
PMID: 35179776
PMC: 9133056.
DOI: 10.1002/ijc.33965.
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
Behrooz A, Talaie Z, Jusheghani F, Los M, Klonisch T, Ghavami S
Int J Mol Sci. 2022; 23(3).
PMID: 35163279
PMC: 8836096.
DOI: 10.3390/ijms23031353.
Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S, Zhang I, Hernandez A, Kraft C, Raj D, Kedda J
Biomolecules. 2021; 11(12).
PMID: 34944514
PMC: 8699739.
DOI: 10.3390/biom11121870.
Autophagy-targeted therapy to modulate age-related diseases: Success, pitfalls, and new directions.
Martins W, Silva M, Pandey K, Maejima I, Ramalho E, Olivon V
Curr Res Pharmacol Drug Discov. 2021; 2:100033.
PMID: 34909664
PMC: 8663935.
DOI: 10.1016/j.crphar.2021.100033.
Combinatorial Regimen of Carbamazepine and Imipramine Exhibits Synergism against Grandmal Epilepsy in Rats: Inhibition of Pro-Inflammatory Cytokines and PI3K/Akt/mTOR Signaling Pathway.
Pottoo F, Salahuddin M, Khan F, Al Dhamen M, Alsaeed W, Gomaa M
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832986
PMC: 8624327.
DOI: 10.3390/ph14111204.
Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide.
Wang Y, Wang X, Wang X, Wu D, Qi J, Zhang Y
J Cell Mol Med. 2021; 25(19):9350-9363.
PMID: 34469035
PMC: 8500960.
DOI: 10.1111/jcmm.16874.
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy.
Brimson J, Prasanth M, Malar D, Brimson S, Thitilertdecha P, Tencomnao T
Expert Opin Ther Targets. 2021; 25(6):435-449.
PMID: 34236922
PMC: 8290373.
DOI: 10.1080/14728222.2021.1952987.
Friend or Foe: Paradoxical Roles of Autophagy in Gliomagenesis.
Batara D, Choi M, Shin H, Kim H, Kim S
Cells. 2021; 10(6).
PMID: 34204169
PMC: 8227518.
DOI: 10.3390/cells10061411.
Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z, Wang Y, Yang T, Xing H, Wang Y, Gao L
Brief Bioinform. 2021; 22(5).
PMID: 33839757
PMC: 8425448.
DOI: 10.1093/bib/bbab032.
Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism.
Hartleben G, Schorpp K, Kwon Y, Betz B, Tsokanos F, Dantes Z
EMBO Mol Med. 2021; 13(4):e12461.
PMID: 33665961
PMC: 8033521.
DOI: 10.15252/emmm.202012461.